Literature DB >> 21376288

10-year analysis of the ATAC trial: wrong conclusion?

Ian F Tannock.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21376288     DOI： 10.1016/S1470-2045(11)70049-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

1.  Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial.

Authors:  Thomas Ruhstaller; Anita Giobbie-Hurder; Marco Colleoni; Maj-Britt Jensen; Bent Ejlertsen; Evandro de Azambuja; Patrick Neven; István Láng; Erik Hugger Jakobsen; Laurence Gladieff; Hervé Bonnefoi; Vernon J Harvey; Simon Spazzapan; Carlo Tondini; Lucia Del Mastro; Corinne Veyret; Edda Simoncini; Lorenzo Gianni; Christoph Rochlitz; Elena Kralidis; Khalil Zaman; Jacek Jassem; Martine Piccart-Gebhart; Angelo Di Leo; Richard D Gelber; Alan S Coates; Aron Goldhirsch; Beat Thürlimann; Meredith M Regan
Journal:  J Clin Oncol       Date:  2018-11-26       Impact factor: 44.544

2.  A balancing act: racial disparities in cardiovascular disease mortality among women diagnosed with breast cancer.

Authors:  Lindsay J Collin; Alyssa N Troeschel; Yuan Liu; Keerthi Gogineni; Kylee Borger; Kevin C Ward; Lauren E McCullough
Journal:  Ann Cancer Epidemiol       Date:  2020-03-31

Review 3.  Breast Cancer in Low- and Middle-Income Countries: Why We Need Pathology Capability to Solve This Challenge.

Authors:  Yehoda M Martei; Lydia E Pace; Jane E Brock; Lawrence N Shulman
Journal:  Clin Lab Med       Date:  2017-12-13       Impact factor: 1.935

4.  The role of hormones and aromatase inhibitors on breast tumor growth and general health in a postmenopausal mouse model.

Authors:  Arunkumar Arumugam; Elaine A Lissner; Rajkumar Lakshmanaswamy
Journal:  Reprod Biol Endocrinol       Date:  2014-07-15       Impact factor: 5.211

5.  Obesity and outcome of post-menopausal women receiving adjuvant letrozole for breast cancer.

Authors:  Jamal Zekri; Kamel Farag; Ahmed Allithy
Journal:  Ecancermedicalscience       Date:  2018-03-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.